Published in Biochem Biophys Res Commun on November 02, 1999
Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest (2006) 1.87
Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav (2008) 1.80
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol (2011) 1.51
Neurotrophin modulation of voltage-gated potassium channels in rat through TrkB receptors is time and sensory experience dependent. J Physiol (2002) 1.37
The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol (2011) 0.98
Estrogen-growth factor interactions and their contributions to neurological disorders. Headache (2008) 0.91
Ca2+, CREB and krüppel: a novel KLF7-binding element conserved in mouse and human TRKB promoters is required for CREB-dependent transcription. Mol Cell Neurosci (2007) 0.81
Changes in the expression of genes associated with intraneuronal amyloid-beta and tau in Alzheimer's disease. J Alzheimers Dis (2010) 0.79
The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer's disease through a toxic synergy with Aβ. Hum Mol Genet (2015) 0.77
Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF). Pharmacol Res (2015) 0.76
Neuritin can normalize neural deficits of Alzheimer's disease. Cell Death Dis (2014) 0.76
Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta. Neurobiol Aging (2015) 0.76
Regulation of a TrkB Alternative Transcript by microRNAs. Dement Geriatr Cogn Dis Extra (2014) 0.75
Oral consumption of α-linolenic acid increases serum BDNF levels in healthy adult humans. Nutr J (2015) 0.75
Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies. Int J Mol Sci (2017) 0.75
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet (1997) 5.47
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 4.97
Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52
The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry (1999) 3.98
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet (1999) 2.42
Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing (1996) 2.32
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17
Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry (1997) 2.05
Attentional control in Alzheimer's disease. Brain (2001) 1.97
The prevalence of osteoarthrosis of the hip requiring total hip replacement in the elderly. Int J Epidemiol (1979) 1.95
The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.71
Clostridium difficile in acute and long-stay elderly patients. Age Ageing (1988) 1.60
Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage (2010) 1.57
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol (2003) 1.53
HSV-1 and risk of Alzheimer's disease. Lancet (1998) 1.47
The diagnosis of vascular dementia in the light of the new criteria. Age Ageing (1996) 1.41
The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders. Age Ageing (1997) 1.40
Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry (1986) 1.37
Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res (1983) 1.29
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem (1983) 1.28
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. Neuropathol Appl Neurobiol (1983) 1.24
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A (2000) 1.17
Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet (1987) 1.16
Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain (1999) 1.14
Progressive systemic sclerosis in the elderly. Postgrad Med J (1979) 1.14
Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol (1991) 1.13
Asymmetry of pathology in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1987) 1.13
Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J Neuroimmunol (2000) 1.13
Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease. Clin Pharmacol Ther (1989) 1.13
Benefits of total hip replacement to older patients and the community. Br Med J (1978) 1.11
Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. Int J Geriatr Psychiatry (2000) 1.11
Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5. Structure (2001) 1.11
Time course and nerve growth factor dependence of inflammation-induced alterations in electrophysiological membrane properties in nociceptive primary afferent neurons. J Neurosci (2001) 1.09
Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat. Pain (2007) 1.09
Hyperinsulinaemia and Alzheimer's disease. Age Ageing (1994) 1.07
Dementia and driving. J R Soc Med (1992) 1.04
Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry (1983) 1.03
Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease. Int J Geriatr Psychiatry (1998) 1.02
Neuronal death in brain infarcts in man. Neuropathol Appl Neurobiol (2000) 1.01
The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease. Int J Geriatr Psychiatry (2000) 1.00
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med (1985) 1.00
Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease. Clin Pharmacol Ther (1993) 0.98
Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol (1992) 0.98
A comparison of total hip replacement in patients aged 69 years or less and 70 years or over. Gerontology (1981) 0.97
Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry (1998) 0.96
Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA. Cerebrovasc Dis (2012) 0.95
The challenge of Alzheimer's disease--no longer a silent epidemic. Health Trends (1988) 0.95
Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet (1994) 0.94
Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol (2005) 0.93
Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience (2010) 0.90
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res (1985) 0.90
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res (1987) 0.90
Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer's disease. Int J Geriatr Psychiatry (1997) 0.90
Cholinergic side-effects of tetrahydroaminoacridine. Lancet (1988) 0.89
Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience (1987) 0.88
The pupillary light reflex in aging and Alzheimer's disease. Aging (Milano) (2001) 0.88
Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Brain Res Mol Brain Res (1989) 0.86
Intranigral injection of capsaicin enhances motor activity and depletes nigral 5-hydroxytryptamine but not substance P. Neuropharmacology (1981) 0.86
Identification of syntaxin 1A as a novel binding protein for presenilin-1. Brain Res Mol Brain Res (2000) 0.86
Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett (1997) 0.86
Immunoreactivity to calcitonin gene-related peptide in the superior olivary complex and cochlea of cat and rat. Hear Res (1987) 0.85
Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer's disease brain using polymerase chain reaction. Biochem Soc Trans (1991) 0.85
Decreased CSF acetylcholinesterase activity in Alzheimer's disease. Lancet (1983) 0.85
Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol (2007) 0.85
Variability in scoring the Hachinski Ischaemic Score. Age Ageing (1995) 0.85
Neuronal accumulation of poly(ADP-ribose) after brain ischaemia. Neuropathol Appl Neurobiol (1999) 0.84
Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor. Nat Biotechnol (1997) 0.84
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Brain (1987) 0.83
Rhabdomyolysis in elderly people after collapse. Br Med J (Clin Res Ed) (1984) 0.83
Cerebrovascular disease in dementia: the importance of atrial fibrillation. Postgrad Med J (1985) 0.83
Age-related changes in the preattentional detection of visual change. Neuroreport (2002) 0.83
Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection. J Chromatogr (1988) 0.83
Cloning of a non-catalytic form of human trkB and distribution of messenger RNA for trkB in human brain. Neuroscience (1994) 0.83
Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease. J Clin Pathol (1984) 0.82
Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man. Neuroreport (1998) 0.81
Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience (2013) 0.81
Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps. J Biochem Biophys Methods (2001) 0.81
Identification and structure of the nerve growth factor binding site on TrkA. Biochem Biophys Res Commun (2001) 0.81
Neural grafting in a rat model of Huntington's disease: striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography. Neuroscience (1987) 0.81
Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Brain Res (1988) 0.81
Acute motor effects of N-methyl-D-aspartic acid and kainic acid applied focally to mesencephalic dopamine cell body regions in the rat. Neurosci Lett (1980) 0.81
Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study. Age Ageing (1989) 0.80
Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease. Neuropathol Appl Neurobiol (2001) 0.80
The aetiology of depression in the carers of dementia sufferers. J Affect Disord (1995) 0.80
Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment. Br J Pharmacol (1981) 0.80
What we have learned from the Myriad trials. J Nutr Health Aging (2009) 0.80
Alzheimer's disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. Biochem Soc Trans (1995) 0.80
Longitudinal diagnosis of memory disorders. Age Ageing (1992) 0.80
Use of a self-administered postal questionnaire when screening for health problems in the elderly. Gerontology (1979) 0.79
Failure to correlate C. pneumoniae with late onset Alzheimer's disease. Neurology (2002) 0.79
Economic aspects of the demand for total hip replacement in the elderly. Age Ageing (1979) 0.79